ArticleNano-micro letters2023
Mixed Cations Enabled Combined Bulk and Interfacial Passivation for Efficient and Stable Perovskite Solar Cells.
Article in Nano-micro letters, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 39 citations in OpenAlex.
- An Absorption-Transport Reconfigurable 2D/3D/2D Architecture Enables Multispectral-Adaptive Bifacial Perovskite Photovoltaics.Advanced materials (Deerfield Beach, Fla.) · 2026Article
- Nature-Inspired Redox Shuttle with Regenerable Antioxidant for Efficient All-Perovskite Tandem Solar Cells.Nano-micro letters · 2026Article
- Enhanced charge carrier transport and defects mitigation of passivation layer for efficient perovskite solar cells.Nature communications · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 4 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Here, we report a mixed GAI and MAI (MGM) treatment method by forming a 2D alternating-cation-interlayer (ACI) phase (n = 2) perovskite layer on the 3D perovskite, modulating the bulk and interfacial defects in the perovskite films simultaneously, leading to the suppressed nonradiative recombination, longer lifetime, higher mobility, and reduced trap density. Consequently, the devices' performance is enhanced to 24.5% and 18.7% for 0.12 and 64 cm
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.